Author:
Hamedi Nadia,Kajbafvala Mehrnaz,ShahAli Shabnam,Pourahmadi MohammadReza,Eshghi Alireza,Estahbanati MohammadReza Modaresi
Abstract
Abstract
Background
Cystic fibrosis (CF) is an autosomal recessive disorder caused by abnormal function of the chloride ion channels and characterized by pancreatic insufficiency and chronic endobronchial airway infection. Pulmonary dysfunction is very common and could lead to a reduction in the quality of life. Airway clearance techniques (ACT) and physical exercises are introduced as one of the main components of treatment. Therefore, it will be of interest to examine the effect of aerobic exercises compared to conventional chest physiotherapy (CPT) on pulmonary function, functional capacity, sputum culture, and quality of life in patients with CF.
Methods
Thirty patients with CF will participate in a double-blind parallel controlled trial containing 18 sessions of treatment. Group A consists of CPT and placebo aerobic exercise, and group B includes aerobic exercise and placebo CPT. Pulmonary function, functional capacity, sputum culture, and quality of life will be evaluated with a spirometry test, 6-min walk test (6MWT), sputum culture test, and the Cystic Fibrosis Questionnaire-Revised (CFQ-R), respectively, before and after the intervention.
Discussion
We will evaluate and compare the effectiveness of aerobic exercises and conventional chest physiotherapy on pulmonary function, functional capacity, sputum culture, and quality of life. Comparing these two treatment patterns can contribute to a better understanding of the effectiveness. Therefore, if there is a significant difference between the two treatments, the superior treatment will be prioritized clinically.
Trial registration
https://www.irct.ir, IRCT20210505051181N5. Registered on 19 February 2023.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Medicine (miscellaneous)
Reference46 articles.
1. Bell SC, Mall MA, Gutierrez H, Macek M, Madge S, Davies JC, et al. The future of cystic fibrosis care: a global perspective. Lancet Respir Med. 2020;8(1):65–124.
2. Dickinson KM, Collaco JM. Cystic fibrosis. Pediatr Rev. 2021;42(2):55–65.
3. National Guideline A. National Institute for Health and Care Excellence: Guidelines. Cystic Fibrosis: Diagnosis and management. London: National Institute for Health and Care Excellence (NICE) Copyright © NICE 2017; 2017.
4. Taylor SL, Leong LEX, Ivey KL, Wesselingh S, Grimwood K, Wainwright CE, et al. Total bacterial load, inflammation, and structural lung disease in paediatric cystic fibrosis. J Cyst Fibros. 2020;19(6):923–30.
5. Mirtajani S, Farnia P, Hassanzad M, Ghanavi J, Farnia P, Velayati A. Geographical distribution of cystic fibrosis; the past 70 years of data analyzis. Biomed Biotechnol Res J (BBRJ). 2017;1(2):105–12.